ArticleThe Lancet regional health. Europe2024

Long-term efficacy and safety of nusinersen in adults with 5q spinal muscular atrophy: a prospective European multinational observational study.

René Günther et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.